- Featured Product
- KD/KO Validated
PLOD2 Monoklonaler Antikörper
PLOD2 Monoklonal Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Maus / IgA
Getestete Reaktivität
human
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1H9E1
Kat-Nr. : 66342-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66342-1-PBS bindet in WB, IHC, Indirect ELISA PLOD2 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Maus / IgA |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | PLOD2 fusion protein Ag5779 |
| Vollständiger Name | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
| Berechnetes Molekulargewicht | 758 aa, 85 kDa |
| Beobachtetes Molekulargewicht | 87 kDa |
| GenBank-Zugangsnummer | BC037169 |
| Gene symbol | PLOD2 |
| Gene ID (NCBI) | 5352 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
PLOD2,also named as LH2, forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. It is a potential novel prognostic factor for HCC patients following surgery. Among the PLOD genes, PLOD2 contributes to cancer prognosis and angiogenesis. Several authors have reported that PLOD2 expression might provide prognostic information about malignant tumours such as glioblastoma. PLOD2 expression is a useful biomarker for the effects of antiangiogenic treatment for malignancy.(PMID:22098155). It has 2 isoforms produced by alternative splicing and seven glycosylation sites.

















